{
  "pmid": "41593652",
  "title": "Chicoric acid prevents motor dysfunction in zebrafish Parkinson's disease model through Nrf2-mediated antioxidant effect.",
  "abstract": "Chicoric acid (CA) has been used as a nutritional supplement, health food, and medicine because of its antioxidant property. This study aimed to investigate whether CA can prevent motor dysfunction in a zebrafish model of Parkinson's disease (PD). AB-strain zebrafish (24 hours post-fertilization) were incubated with 25 µM 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) with or without CA for 5 days. The levels of malondialdehyde, glutathione, reactive oxygen species and the activities of antioxidant enzymes in brain tissue were measured. Additionally, the expression of molecules from the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway were assayed by Western blot. Compared with the control group, zebrafish in the MPTP group had impaired motor function. Treatment with CA prevented the changes of the total distance, the mean speed, and attenuated dopaminergic neuronal degeneration in the PD zebrafish model. CA also reduced the levels of malondialdehyde, reactive oxygen species and increased the antioxidant enzymes and glutathione level. Furthermore, CA augmented the expression of Nrf2, NQO1, HO-1, GCLC, and GCLM in the brain of the PD zebrafish model. Our findings suggest the protective effects of CA may be associated with regulating the antioxidant system, possibly involving the Nrf2 signaling pathway.",
  "journal": "BMC complementary medicine and therapies",
  "year": "2026",
  "authors": [
    {
      "lastName": "Zhang",
      "foreName": "Xiaohan",
      "initials": "X",
      "affiliation": ""
    },
    {
      "lastName": "Li",
      "foreName": "Mingyue",
      "initials": "M",
      "affiliation": ""
    },
    {
      "lastName": "Zhang",
      "foreName": "Huilin",
      "initials": "H",
      "affiliation": ""
    },
    {
      "lastName": "Che",
      "foreName": "Xin",
      "initials": "X",
      "affiliation": ""
    },
    {
      "lastName": "Zhang",
      "foreName": "Guirong",
      "initials": "G",
      "affiliation": ""
    },
    {
      "lastName": "Han",
      "foreName": "Bing",
      "initials": "B",
      "affiliation": ""
    }
  ],
  "keywords": [
    "Chicoric acid",
    "Motor function",
    "Oxidative stress",
    "Parkinson's disease",
    "Zebrafish"
  ],
  "doi": "10.1186/s12906-026-05271-z",
  "pmcId": null,
  "meshTerms": [],
  "rawXml": "<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2025//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd\">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">41593652</PMID><DateRevised><Year>2026</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2662-7671</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2026</Year><Month>Jan</Month><Day>27</Day></PubDate></JournalIssue><Title>BMC complementary medicine and therapies</Title><ISOAbbreviation>BMC Complement Med Ther</ISOAbbreviation></Journal><ArticleTitle>Chicoric acid prevents motor dysfunction in zebrafish Parkinson's disease model through Nrf2-mediated antioxidant effect.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1186/s12906-026-05271-z</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Chicoric acid (CA) has been used as a nutritional supplement, health food, and medicine because of its antioxidant property. This study aimed to investigate whether CA can prevent motor dysfunction in a zebrafish model of Parkinson's disease (PD).</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">AB-strain zebrafish (24&#xa0;hours post-fertilization) were incubated with 25 &#xb5;M 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) with or without CA for 5 days. The levels of malondialdehyde, glutathione, reactive oxygen species and the activities of antioxidant enzymes in brain tissue were measured. Additionally, the expression of molecules from the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway were assayed by Western blot.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Compared with the control group, zebrafish in the MPTP group had impaired motor function. Treatment with CA prevented the changes of the total distance, the mean speed, and attenuated dopaminergic neuronal degeneration in the PD zebrafish model. CA also reduced the levels of malondialdehyde, reactive oxygen species and increased the antioxidant enzymes and glutathione level. Furthermore, CA augmented the expression of Nrf2, NQO1, HO-1, GCLC, and GCLM in the brain of the PD zebrafish model.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"CONCLUSIONS\">Our findings suggest the protective effects of CA may be associated with regulating the antioxidant system, possibly involving the Nrf2 signaling pathway.</AbstractText><CopyrightInformation>&#xa9; 2026. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Xiaohan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Mitochondria and Healthy Aging, College of Life Science, Yantai University, Yantai, Shandong, 264005, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Mingyue</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>R&amp;D Department, Yinfeng Biological Group Co., Ltd., Jinan, Shandong, 250102, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Huilin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Mitochondria and Healthy Aging, College of Life Science, Yantai University, Yantai, Shandong, 264005, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Che</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Guirong</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>R&amp;D Department, Yinfeng Biological Group Co., Ltd., Jinan, Shandong, 250102, PR China. guirong_zhang@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Han</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center for Mitochondria and Healthy Aging, College of Life Science, Yantai University, Yantai, Shandong, 264005, PR China. pharmacology533@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>ZR2020MH377</GrantID><Agency>Natural Science Foundation of Shandong Province</Agency><Country/></Grant><Grant><GrantID>ZR2020MH377</GrantID><Agency>Natural Science Foundation of Shandong Province</Agency><Country/></Grant><Grant><GrantID>ZR2020MH377</GrantID><Agency>Natural Science Foundation of Shandong Province</Agency><Country/></Grant><Grant><GrantID>ZR2020MH377</GrantID><Agency>Natural Science Foundation of Shandong Province</Agency><Country/></Grant><Grant><GrantID>ZR2020MH377</GrantID><Agency>Natural Science Foundation of Shandong Province</Agency><Country/></Grant><Grant><GrantID>ZR2020MH377</GrantID><Agency>Natural Science Foundation of Shandong Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2026</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Complement Med Ther</MedlineTA><NlmUniqueID>101761232</NlmUniqueID><ISSNLinking>2662-7671</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Chicoric acid</Keyword><Keyword MajorTopicYN=\"N\">Motor function</Keyword><Keyword MajorTopicYN=\"N\">Oxidative stress</Keyword><Keyword MajorTopicYN=\"N\">Parkinson's disease</Keyword><Keyword MajorTopicYN=\"N\">Zebrafish</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: This study was conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals (No. 8023, revised in 1996). And this study was approved by the Animal Care and Use Committee of Yantai University (YTDX20210425). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2025</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2026</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2026</Year><Month>1</Month><Day>28</Day><Hour>7</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2026</Year><Month>1</Month><Day>28</Day><Hour>7</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2026</Year><Month>1</Month><Day>28</Day><Hour>0</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">41593652</ArticleId><ArticleId IdType=\"doi\">10.1186/s12906-026-05271-z</ArticleId><ArticleId IdType=\"pii\">10.1186/s12906-026-05271-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rabiei Z, Solati K, Amini-Khoei H. Phytotherapy in treatment of parkinson&#x2019;s disease: a review. Pharm Biol. 2019;57(1):355&#x2013;62. https://doi.org/10.1080/13880209.2019.1618344.</Citation></Reference><Reference><Citation>Sallinen V, Torkko V, Sundvik M, Reenil&#xe4; I, Khrustalyov D, Kaslin J, Panula P. MPTP and MPP<sup>+</sup> target specific aminergic cell populations in larval zebrafish. J Neurochem. 2009;108(3):719&#x2013;31. https://doi.org/10.1111/j.1471-4159.2008.05793.x.</Citation></Reference><Reference><Citation>Bretaud S, Lee S, Guo S. Sensitivity of zebrafish to environmental toxins implicated in parkinson&#x2019;s disease. Neurotoxicol Teratol. 2004;26(6):857&#x2013;64. https://doi.org/10.1016/j.ntt.2004.06.014.</Citation></Reference><Reference><Citation>Doyle JM, Croll RP. A critical review of zebrafish models of parkinson&#x2019;s disease. Front Pharmacol. 2022;13:835827. https://doi.org/10.3389/fphar.2022.835827.</Citation></Reference><Reference><Citation>Aborode AT, Pustake M, Awuah WA, et al. Targeting oxidative stress mechanisms to treat alzheimer&#x2019;s and parkinson&#x2019;s disease: A critical review. Oxid Med Cell Longev. 2022;2022:7934442. https://doi.org/10.1155/2022/7934442.</Citation></Reference><Reference><Citation>Cacabelos R. Parkinson&#x2019;s disease: from pathogenesis to pharmacogenomics. Int J Mol Sci. 2017;18(3):551. https://doi.org/ARTN55110.3390/ijms18030551.</Citation></Reference><Reference><Citation>Wang Y, Gao L, Chen J, et al. Pharmacological modulation of Nrf2/HO-1 signaling pathway as a therapeutic target of parkinson&#x2019;s disease. Front Pharmacol. 2021;12:757161. https://doi.org/10.3389/fphar.2021.757161.</Citation></Reference><Reference><Citation>Schapira AH. Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease. Neurology. 2009;72(7 Suppl):44&#x2013;S50. https://doi.org/10.1212/WNL.0b013e3181990438.</Citation></Reference><Reference><Citation>Baweja GS, Gupta S, Kumar B, Patel P, Asati V. Recent updates on structural insights of MAO-B inhibitors: a review on target-based approach. Mol Diversity. 2024;28(3):1823&#x2013;45. https://doi.org/10.1007/s11030-023-10634-6.</Citation></Reference><Reference><Citation>Rascol O, Fitzer-Attas CJ, Hauser R, Jankovic J, Lang A, Langston JW, Melamed E, Poewe W, Stocchi F, Tolosa E, Eyal E, Weiss YM, Olanow CW. A double-blind, delayed-start trial of Rasagiline in parkinson&#x2019;s disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. Lancet Neurol. 2011;10(5):415&#x2013;23. https://doi.org/10.1016/S1474-4422(11)70073-4.</Citation></Reference><Reference><Citation>Agarwal P, Wang Y, Buchman AS, Holland TM, Bennett DA, Morris MC. Dietary antioxidants associated with slower progression of parkinsonian signs in older adults. Nutr Neurosci. 2022;25(3):550&#x2013;7. https://doi.org/10.1080/1028415X.2020.1769411.</Citation></Reference><Reference><Citation>Street RA, Sidana J, Prinsloo G. Cichorium intybus: traditional Uses, Phytochemistry, Pharmacology, and toxicology. Evid Based Complement Alternat Med. 2013;2013:579319. https://doi.org/10.1155/2013/579319.</Citation></Reference><Reference><Citation>Peng Y, Sun Q, Park Y. The bioactive effects of Chicoric acid as a functional food ingredient. J Med Food. 2019;22(7):645&#x2013;52. https://doi.org/10.1089/jmf.2018.0211.</Citation></Reference><Reference><Citation>Wang N, Li R, Feng B, Cheng Y, Guo Y, Qian H. Chicoric acid prevents neuroinflammation and neurodegeneration in a mouse parkinson&#x2019;s disease model: immune response and transcriptome profile of the spleen and colon. Int J Mol Sci. 2022;23(4):2031. https://doi.org/10.3390/ijms23042031.</Citation></Reference><Reference><Citation>Wang N, Feng BN, Hu B, Cheng YL, Guo YH, Qian H. Neuroprotection of Chicoric acid in a mouse model of parkinson&#x2019;s disease involves gut microbiota and TLR4 signaling pathway. Food Funct. 2022;13(4):2019&#x2013;32. https://doi.org/10.1039/d1fo02216d.</Citation></Reference><Reference><Citation>Liu Q, Chen Y, Shen C, et al. Chicoric acid supplementation prevents systemic inflammation-induced memory impairment and amyloidogenesis via Inhibition of NF-&#x3ba;B. FASEB J. 2017;31(4):1494&#x2013;507. https://doi.org/10.1096/fj.201601071R.</Citation></Reference><Reference><Citation>Mu Y, Yu J, Ji W, Chen L, Wang X, Yan B. Alleviation of Pb<sup>2+</sup> pollution-induced oxidative stress and toxicity in microglial cells and zebrafish larvae by Chicoric acid. Ecotoxicol Environ Saf. 2019;180:396&#x2013;402. https://doi.org/10.1016/j.ecoenv.2019.05.040.</Citation></Reference><Reference><Citation>Ma J, Li M, Kalavagunta PK, et al. Protective effects of cichoric acid on H<sub>2</sub>O<sub>2</sub>-induced oxidative injury in hepatocytes and larval zebrafish models. Biomed Pharmacother. 2018;104:679&#x2013;85. https://doi.org/10.1016/j.biopha.2018.05.081.</Citation></Reference><Reference><Citation>Najib NHM, Nies YH, Abd Halim SAS, et al. Modeling parkinson&#x2019;s disease in zebrafish. CNS Neurol Disord Drug Targets. 2020;19(5):386&#x2013;99. https://doi.org/10.2174/1871527319666200708124117.</Citation></Reference><Reference><Citation>Avdesh A, Chen M, Martin-Iverson MT, et al. Regular care and maintenance of a zebrafish (Danio rerio) laboratory: an introduction. J Vis Exp. 2012;69e4196. https://doi.org/10.3791/4196.</Citation></Reference><Reference><Citation>Chang X, Dong S, Bai W, Di Y, Gu R, Liu F, Zhao B, Wang Y, Liu X. Methylated metabolites of Chicoric acid ameliorate hydrogen peroxide (H2O2)-Induced oxidative stress in HepG2 cells. J Agric Food Chem. 2021;69(7):2179&#x2013;89. https://doi.org/10.1021/acs.jafc.0c07521.</Citation></Reference><Reference><Citation>Ding XQ, Jian TY, Gai YN, Niu GT, Liu Y, Meng XH, Li J, Lyu H, Ren BR, Chen J. Chicoric acid attenuated renal tubular injury in HFD-Induced chronic kidney disease mice through the promotion of mitophagy via the Nrf2/PINK/Parkin pathway. J Agric Food Chem. 2022;70(9):2923&#x2013;35. https://doi.org/10.1021/acs.jafc.1c07795.</Citation></Reference><Reference><Citation>Han B, Zhao H. Effects of hydroxysafflor yellow A in the Attenuation of MPTP neurotoxicity in mice. Neurochem Res. 2010;35(1):107&#x2013;13. https://doi.org/10.1007/s11064-009-0035-4.</Citation></Reference><Reference><Citation>Wang T, Shan SY, Han B, Zhang LM, Fu FH. Salvianolic acid A exerts antiamnesic effect on diazepam-induced anterograde amnesia in mice. Neurochem Res. 2011;36(1):103&#x2013;8. https://doi.org/10.1007/s11064-010-0270-8.</Citation></Reference><Reference><Citation>Du Y, Guo Q, Shan M, et al. Spatial and Temporal distribution of dopaminergic neurons during development in zebrafish. Front Neuroanat. 2016;10:115. https://doi.org/10.3389/fnana.2016.00115. eCollection 2016.</Citation></Reference><Reference><Citation>Vishwas S, Kumar R, Khursheed R, et al. Expanding arsenal against neurodegenerative diseases using Quercetin based nanoformulations: breakthroughs and bottlenecks. Curr Neuropharmacol. 2023;21(7):1558&#x2013;74. https://doi.org/10.2174/1570159x20666220810105421.</Citation></Reference><Reference><Citation>de Abreu MS, Genario R, Giacomini ACVV, et al. Zebrafish as a model of neurodevelopmental disorders. Neuroscience. 2020;445:3&#x2013;11. https://doi.org/10.1016/j.neuroscience.2019.08.034. https://doi.org/https://doi.org/.</Citation></Reference><Reference><Citation>Razali K, Othman N, Mohd Nasir MH, et al. The promise of the zebrafish model for parkinson&#x2019;s disease: today&#x2019;s science and tomorrow&#x2019;s treatment. Front Genet. 2021;12:655550. https://doi.org/10.3389/fgene.2021.655550.</Citation></Reference><Reference><Citation>Manzanilla B, Robles J. Antiradical properties of curcumin, caffeic acid phenethyl ester, and Chicoric acid: a DFT study. J Mol Model. 2022;28(3):68. https://doi.org/10.1007/s00894-022-05056-4.</Citation></Reference><Reference><Citation>Wang M, Zhao J, Wu L, Ma T. Effects of 4-epianhydrotetracycline on oxidative stress in zebrafish (Danio rerio) embryos. Sci Total Environ. 2021;796:149047. https://doi.org/10.1016/j.scitotenv.2021.149047.</Citation></Reference><Reference><Citation>Kagan DB, Liu H, Hutnik CM. Efficacy of various antioxidants in the protection of the retinal pigment epithelium from oxidative stress. Clin Ophthalmol. 2012;6:1471&#x2013;6. https://doi.org/10.2147/opth.S35139.</Citation></Reference><Reference><Citation>You L, Peng H, Liu J, et al. Catalpol protects ARPE-19 cells against oxidative stress via activation of the Keap1/Nrf2/ARE pathway. Cells. 2021;10(10):2635. https://doi.org/10.3390/cells10102635.</Citation></Reference><Reference><Citation>Magesh S, Chen Y, Hu L. Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents. Med Res Rev. 2012;32(4):687&#x2013;726. https://doi.org/10.1002/med.21257.</Citation></Reference><Reference><Citation>Trist BG, Hare DJ, Double KL. Oxidative stress in the aging substantia Nigra and the etiology of parkinson&#x2019;s disease. Aging Cell. 2019;18(6):e13031. https://doi.org/10.1111/acel.13031.</Citation></Reference><Reference><Citation>Prasad EM, Hung SY. Behavioral tests in Neurotoxin-Induced animal models of parkinson&#x2019;s disease. Antioxid (Basel Switzerland). 2020;9(10):1007. https://doi.org/10.3390/antiox9101007.</Citation></Reference><Reference><Citation>Parga JA, Rodriguez-Perez AI, Garcia-Garrote M, Rodriguez-Pallares J, Labandeira-Garcia JL. NRF2 activation and downstream effects: focus on parkinson&#x2019;s disease and brain angiotensin. Antioxid (Basel Switzerland). 2021;10(11):1649. https://doi.org/10.3390/antiox10111649.</Citation></Reference><Reference><Citation>Choi JW, Kim S, Yoo JS, Kim HJ, Kim HJ, Kim BE, Lee EH, Lee YS, Park JH, Park KD. Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of parkinson&#x2019;s disease. Eur J Med Chem. 2021;212:113103. https://doi.org/10.1016/j.ejmech.2020.113103.</Citation></Reference><Reference><Citation>Wen ZH, Chiu YJ, Yang SN, Guo BL, Feng CW, Chunag JM, Chen NF, Chen WF. The neuroprotective effects of the crinoid natural compound rhodoptilometrin in parkinson&#x2019;s disease experimental models: implications for ER stress and autophagy modulation. ACS Chem Neurosci. 2025;16(13):2376&#x2013;86. https://doi.org/10.1021/acschemneuro.5c00087.</Citation></Reference><Reference><Citation>Li M, Zhou F, Xu T, Song H, Lu B. Acteoside protects against 6-OHDA-induced dopaminergic neuron damage via Nrf2-ARE signaling pathway. Food Chem Toxicology: Int J Published Br Industrial Biol Res Association. 2018;119:6&#x2013;13. https://doi.org/10.1016/j.fct.2018.06.018.</Citation></Reference><Reference><Citation>Nunes ME, M&#xfc;ller TE, Braga MM, Fontana BD, Quadros VA, Marins A, Rodrigues C, Menezes C, Rosemberg DB, Loro VL. Chronic treatment with Paraquat induces brain Injury, changes in antioxidant defenses System, and modulates behavioral functions in zebrafish. Mol Neurobiol. 2017;54(6):3925&#x2013;34. https://doi.org/10.1007/s12035-016-9919-x.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>",
  "fetched_at": "2026-01-29T18:51:21.329Z"
}